Evidence map›Paper›PMID 41952119›Full record

ArticleBMC cardiovascular disorders2026

Discriminating established cardiovascular disease using a novel multiterritory ultrasound plaque burden measure (wTPT): findings from the P-SONAR study.

Gunnar Austad, Jonn Terje Geitung, Owen Thomas, Serena Tonstad

Erratum issued Registry-linked trialAbstract readMulticenter StudyComparative Study
In one paragraph

Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06933745 (Ultrasound of Carotid and Femoral Plaque Burden and Non-alcoholic Fatty Liver Disease as Predictors of Cardiovascular Disease), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06933745 completednot on this map

Ultrasound of Carotid and Femoral Plaque Burden and Non-alcoholic Fatty Liver Disease as Predictors of Cardiovascular Disease

Typeobservational_patient_registrySponsorUniversity Hospital, AkershusRan2022 to 2025Enrolled21,029ConditionsCardiovascular Diseases, Fatty Liver, Atherosclerosis of Femoral Artery, Carotid Artery Plaque
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Gunnar AustadDepartment of Preventive Cardiology, Oslo University Hospital, Oslo, N-0424, Norway. gunnar.austad@gmail.com.
Jonn Terje GeitungDepartment of Radiology and Nuclear Medicine, Akershus University Hospital, Lørenskog, N-1478, Norway.
Owen ThomasHealth Services Research Unit, Akershus University Hospital, Lørenskog, N-1478, Norway.
Serena TonstadDepartment of Preventive Cardiology, Oslo University Hospital, Oslo, N-0424, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveUltrasound-imaging of subclinical atherosclerosis may refine cardiovascular (CV) risk assessment, but quantification methods vary and often include carotid arteries only. Because atherosclerosis is multiterritory, global (carotid–femoral) plaque quantification may better reflect systemic burden. We examined whether a novel multiterritory measure, weighted total plaque thickness (wTPT), better discriminates established CV disease than traditional risk factors and plaque measures.

methodsIn 5 418 participants (59.8 ± 8.1 years; 53.0% women) from the Prospective Screening Of Non-invasive Atherosclerosis Risk study, plaque burden was assessed across 12 carotid and femoral segments using wTPT, maximal plaque thickness (MPT), plaque count, and number of arteries with plaque. Discrimination of prior CV disease was evaluated using c-statistics, net reclassification improvement (NRI), and integrated discrimination improvement (IDI).

resultsGlobal wTPT showed the strongest discrimination of established CV disease (c-statistic 0.85 [95% CI: 0.83–0.87]), outperforming alternative plaque measures (p < 0.001). Adding global wTPT to risk factors improved discrimination from 0.84 to 0.89 (95% CI: 0.87–0.91), NRI 0.71 (95% CI: 0.57–0.84) and IDI 0.058 (95% CI: 0.004–0.071). Femoral wTPT outperformed carotid wTPT (p < 0.001), and global wTPT exceeded both (p = 0.014). Across wTPT quartiles, odds of prior CV disease increased stepwise: 2.0 (95% CI: 0.89–4.4), 4.2 (95% CI: 2.0–8.6), and 10.0 (95% CI: 5.0–20.1) versus the lowest quartile.

conclusionGlobal wTPT showed superior discrimination of established CV disease and added substantial incremental discriminative value beyond standard risk factors. These findings support wTPT as a marker of systemic atherosclerosis and a strong candidate for future outcome-based risk refinement. If prospectively validated, wTPT may contribute to improved risk stratification by identifying individuals with a high systemic atherosclerotic burden.

trial registrationClinicaltrials.gov. Identifier: NCT06933745. Registered 22 april 2025.

Indexed as

Carotid ArteriesCarotid Artery DiseasesFemoral ArteryPeripheral Arterial DiseasePlaque, AtheroscleroticUltrasonography, Carotid ArteriesAgedAsymptomatic DiseasesFemaleHeart Disease Risk FactorsHumansMaleMiddle AgedObserver VariationPredictive Value of TestsPrognosisCardiovascular diseaseCardiovascular riskNORRISK-2Peripheral artery diseasePlaque burdenRisk predictionSubclinical atherosclerosisUltrasonography

Identifiers

PMID41952119
PMCPMC13202812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.